Sameer Kamlesh Merchant, Promoter, CEO and Managing Director of laxmi dental Limited, has acquired additional equity shares in the company through open market transactions, as disclosed in a regulatory filing dated March 31, 2026.

Share Acquisition Details

The acquisition involved 17,179 equity shares purchased on March 30, 2026, through open market transactions. This represents 0.03% of the company's total share capital and diluted share capital.

Shareholding Pattern Changes

Following the acquisition, Merchant's total shareholding in Laxmi Dental Limited has increased marginally but demonstrates continued confidence in the company's prospects.

Company Capital Structure

Laxmi Dental Limited's equity share capital structure remains unchanged following this transaction. The company maintains its existing capital base with no dilution from the promoter's market purchase.

Regulatory Compliance

The disclosure was made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, and communicated to both BSE Limited and National Stock Exchange of India Limited. The company's shares are listed on both exchanges, trading under scrip code 544339 on BSE and symbol LAXMIDENTL on NSE.

This acquisition reflects the promoter's continued investment in the company and adherence to regulatory disclosure requirements for substantial shareholding changes.

Laxmi Dental Limited's Board of Directors held a significant meeting on March 26, 2026, approving multiple strategic decisions including a major amalgamation scheme and key corporate appointments. The meeting, which commenced at 05:00 P.M. (IST) and concluded at 06:05 P.M. (IST), addressed several critical business matters under Regulation 30 of SEBI Listing Regulations.

Scheme of Amalgamation Approved

The board approved a comprehensive scheme of amalgamation between Bizdent Devices Private Limited (Transferor Company) and Laxmi Dental Limited (Transferee Company) under Sections 230 and 233 of the Companies Act, 2013. The scheme is subject to necessary statutory and regulatory approvals, including approval from the Regional Director, Stock Exchanges, and other regulatory authorities.

The amalgamation is designed to consolidate businesses and create operational synergies while establishing a stronger financial base. Key benefits include improved organizational capability, enhanced cash management efficiency, cost savings through rationalization of business processes, and elimination of administrative duplication.

Financial Position of Merging Entities

The financial details of both companies demonstrate substantial business operations across multiple periods:

Key Appointments and Re-appointments

The board approved several important appointments to strengthen the company's operational framework:

Tax Auditor Re-appointment:

Internal Auditor Appointment:

Executive Designation Changes

The board approved strategic designation changes for key executives to enhance operational leadership:

Policy Updates and ESOP Surrender

The board approved amendments to 17 corporate policies in compliance with latest SEBI regulations, including Nomination and Remuneration Policy, Risk Management Policy, Corporate Social Responsibility Policy, and various codes of conduct.

Additionally, the board noted the surrender of 32,538 Employee Stock Options by Mr. Mitesh Kariya under the Laxmi Dental Employee Stock Option Scheme 2024:

Related Party Transaction Compliance

The amalgamation involves related parties as Bizdent Devices is a wholly-owned subsidiary of Laxmi Dental Limited. However, the Ministry of Corporate Affairs has clarified that transactions under Compromise, Arrangements and Amalgamations provisions do not fall within related party transaction purview under Section 188 of the Companies Act, 2013. Furthermore, SEBI Listing Regulation 23(5)(b) exempts related party transaction provisions between holding companies and wholly-owned subsidiaries.